2-Chloro-N-(1-(3,4-dichlorobenzyl)-2,3-dioxoindolin-5-yl)acetamide

ID: ALA4438893

Chembl Id: CHEMBL4438893

PubChem CID: 149941375

Max Phase: Preclinical

Molecular Formula: C17H11Cl3N2O3

Molecular Weight: 397.64

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CCl)Nc1ccc2c(c1)C(=O)C(=O)N2Cc1ccc(Cl)c(Cl)c1

Standard InChI:  InChI=1S/C17H11Cl3N2O3/c18-7-15(23)21-10-2-4-14-11(6-10)16(24)17(25)22(14)8-9-1-3-12(19)13(20)5-9/h1-6H,7-8H2,(H,21,23)

Standard InChI Key:  CPHOGWQSGAPBLS-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4438893

    ---

Associated Targets(Human)

Rec1 (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Z-138 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Granta-519 (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JeKo-1 (376 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Maver1 (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 397.64Molecular Weight (Monoisotopic): 395.9835AlogP: 3.90#Rotatable Bonds: 4
Polar Surface Area: 66.48Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.22CX Basic pKa: CX LogP: 3.52CX LogD: 3.52
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.63Np Likeness Score: -1.63

References

1. Yu S, Liu Y, Zhang Z, Zhang J, Zhao G..  (2019)  Design, synthesis and biological evaluation of novel 2,3-indolinedione derivatives against mantle cell lymphoma.,  27  (15): [PMID:31229421] [10.1016/j.bmc.2019.06.009]

Source